JELIKALITE LLC

NEW YORK, NY · Medtech · Private

Wearable transcranial photobiomodulation (tPBM) device with integrated EEG feedback for personalized autism therapy in children

Grants
$1.4M
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
28
6 granted · 22 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I:EEG-guided intelligent transcranial photobiomodulation to reduce symptoms of autism$276,000
Federal grantNational Science Foundation · Phase II · SBIR Phase II: EEG-guided intelligent transcranial photobiomodulation to reduce symptoms of autism$1,148,025
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2157ADIALANTE L.L.C.——
2158CONSTANTIAM BIOSCIENCES INC.——
2159STYLOSONIC LLC——
2160JELIKALITE LLC——
2161Regenexx, LLC—$10M
2162Moai Technologies L.L.C.——
2163FILTRO MEDICAL INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 6 granted of 28

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.